Fig. 2From: LPA1 antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosisLung fibrosis (as measured by QLF) correlations with FVC. Scatterplots and linear regression line predicting baseline (A) and CFB (B) whole lung percent fibrosis from baseline and CFB FVC, respectively. CFB change from baseline; ECM extracellular matrix; FVC forced vital capacity; QLF quantitative lung fibrosisBack to article page